France, Germany, Canada and several other nations suspended the use of the Oxford-AstraZeneca vaccine back in March due to claims of blood clots. This was after blood clots were found in a small number of individuals who have had the vaccine. The manufactures, as well as the WHO, responded saying that there is little to no risk involved with getting the vaccine. Analysts are alleging that politics may be behind the decisions with EU countries irate at AZ for not fulfilling orders or Canada wanting to aid a rival vaccine manufacturer. Most countries have since resumed administration of the vaccine.